Company facts
- Headquarters
- Richmond, California
- Most recent report
- 8-K, filed Oct 16, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1001233
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 56
News 8 of 178
- 8-K Current report on a material event Oct 16, 2026
- 8-K Acquisition or disposal closed Sep 21, 2026
- 8-K Acquisition or disposal closed Sep 8, 2026
- 8-K Significant contract Aug 28, 2026
- 8-K Other events Aug 13, 2026
- 8-K Current report on a material event Aug 12, 2026
- 8-K Current report on a material event Jul 20, 2026
- 8-K Other events Jul 1, 2026
Prospectuses and Registrations 8 of 44
- 25-NSE Notice that a security was delisted Oct 7, 2026
- 424B5 Prospectus supplement for an offering Feb 4, 2026
- FWP Free writing prospectus Feb 3, 2026
- S-8 Registration statement for an employee plan Aug 8, 2025
- 424B5 Prospectus supplement for an offering May 13, 2025
- FWP Free writing prospectus May 13, 2025
- S-8 Registration statement for an employee plan Nov 12, 2024
- S-3 Shelf registration statement Nov 12, 2024
Proxies 8 of 28
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 19, 2024
- PRE 14A Preliminary proxy statement Apr 3, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2023
- PRE 14A Preliminary proxy statement Apr 5, 2023
- DEFA14A Extra proxy material Apr 29, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 2, 2021
Ownership 8 of 658
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade May 27, 2026
- 4 Insider reported a trade May 27, 2026
- 4 Insider reported a trade May 27, 2026
- 4 Insider reported a trade May 27, 2026
- 4 Insider reported a trade May 27, 2026
- SCHEDULE 13G Large holder reported a passive stake May 15, 2026
- 4 Insider reported a trade Apr 23, 2026
Other 8 of 36
- NT 10-Q Notice that a quarterly report will be late Aug 17, 2026
- ARS Annual report sent to shareholders Apr 30, 2025
- EFFECT Notice that a registration became effective Nov 19, 2024
- CORRESP Reply to SEC staff Nov 18, 2024
- UPLOAD Comment letter from SEC staff Nov 18, 2024
- ARS Annual report sent to shareholders Apr 19, 2024
- EFFECT Notice that a registration became effective Apr 21, 2023
- ARS Annual report sent to shareholders Apr 17, 2023
Everything here comes from Sangamo Therapeutics, Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.